MELESSA MATTIS: Open Payments
NPI 1467908947 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$507 in 20 payments from 11 companies in 2025. Trend: 2023 $557 · 2024 $422 · 2025 $507
Food & beverage: $507
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 7 | $201 |
| ViiV Healthcare Company | 1 | $82 |
| SHIELD THERAPEUTICS INC | 3 | $46 |
| PFIZER INC. | 2 | $36 |
| Merck Sharp & Dohme LLC | 1 | $24 |
| Hologic Sales and Service, LLC | 1 | $23 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| Exact Sciences Corporation | 1 | $21 |
| Amgen Inc. | 1 | $20 |
| Dynavax Technologies Corporation | 1 | $18 |
Products named: ZEPBOUND, MOUNJARO, DOVATO, ACCRUFER, PREVNAR 20, GARDASIL 9, APTIMA, CAPLYTA.
Industry payments across CA — which companies pay providers there.
